MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · IEX Real-Time Price · USD
3.560
-0.080 (-2.20%)
Jul 22, 2024, 10:03 AM EDT - Market open
MAIA Biotechnology Employees
MAIA Biotechnology had 13 employees as of December 31, 2023. The number of employees decreased by 5 or -27.78% compared to the previous year.
Employees
13
Change (1Y)
-5
Growth (1Y)
-27.78%
Revenue / Employee
n/a
Profits / Employee
-$1,824,883
Market Cap
76.65M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 13 | -5 | -27.78% |
| Dec 31, 2022 | 18 | 9 | 100.00% |
| Dec 31, 2021 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 208 |
| Marinus Pharmaceuticals | 166 |
| Affimed | 76 |
| Boundless Bio | 72 |
| PMV Pharmaceuticals | 63 |
| Leap Therapeutics | 54 |
| Milestone Pharmaceuticals | 47 |
| Ikena Oncology | 43 |
MAIA News
- 6 weeks ago - MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA's Approval of a Telomerase Inhibitor Agent Therapy - Business Wire
- 6 weeks ago - MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent - Business Wire
- 6 weeks ago - MAIA Biotechnology Reveals New Clinical Data Showing THIO's Strong Efficacy in Non-Small Cell Lung Cancer - Business Wire
- 2 months ago - MAIA Biotechnology to Present at the BIO International Convention 2024 - Business Wire
- 2 months ago - MAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting - Business Wire
- 2 months ago - MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement - Business Wire
- 3 months ago - MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement - Business Wire
- 3 months ago - MAIA Biotechnology Announces $1.00 Million Private Placement - Business Wire